Cafepharma Today

May 28 2025 - GLP-1 prescriptions for weight loss soar, despite obstacles
GLP-1 prescriptions for weight loss soar, despite obstacles
FDA approves use of Sanofi's meningococcal vaccine in infants
GSK's $66M bet on Spero's rejected UTI antibiotic pays off with a phase 3 win
AbbVie's Allergan Aesthetics unit plots 202 layoffs after recent sales slide
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Dividends, Drug Stocks And Owner Earnings
Seeking Alpha
Friday, January 20, 2012 - 9:59am
tags:
dividends, drug stocks, Merck, Eli Lilly, Pfizer, Bristol-Myers Squibb
Genzyme, Veracyte announce global co-promotion agreement
The Fly on the Wall
Friday, January 20, 2012 - 9:57am
tags:
Genzyme, Veracyte, Afirma Thyroid FNA Analysis
Why Prolor Biotech Is Rising And Other Attractive Prospects
Seeking Alpha
Friday, January 20, 2012 - 9:55am
tags:
Prolor, Abbott Laboratories, Alnylam, GSK, Merck, Pfizer, Lilly, Roche
Merck to settle Canada Vioxx suits for up to C$37M
Yahoo/AP
Friday, January 20, 2012 - 9:54am
tags:
Merck, Canada, Vioxx, settlements
Alnylam Pharma To Cut 33% Of Jobs
NASDAQ.com
Thursday, January 19, 2012 - 6:47pm
tags:
Alnylam, layoffs
Gardasil vs. Cervarix: How are MDs vaccinating against HPV?
Fierce Pharma/Sermo
Thursday, January 19, 2012 - 12:07pm
tags:
HPV, Merck, Gardasil, Cervarix, vaccines, GSK
AZ chief: Emerging markets are tougher than you think
Fierce Pharma
Thursday, January 19, 2012 - 12:05pm
tags:
AstraZeneca, emerging markets, David Brennan, Pharma CEOs
J&J to pay $158 million to settle Risperdal case
Markewatch
Thursday, January 19, 2012 - 12:03pm
tags:
settlements, JNJ, Risperdal
Gilead's Viread new formulations approved by FDA for use by children with HIV
Yahoo/Fly on the Wall
Thursday, January 19, 2012 - 11:13am
tags:
Viread, Gilread, HIV, FDA
Biopharma Stocks To Watch This Week
Seeking Alpha
Thursday, January 19, 2012 - 11:12am
tags:
BioDelivery Sciences, Biovest International, Celldex, MannKind, NovaBay Pharmaceuticals, Keryx, ImmunoCellular, Cel-Sci, Dendreon, Generex, Human Genome Sciences
MannKind Is Simply Running Out Of Cash
Seeking Alpha
Thursday, January 19, 2012 - 11:09am
tags:
cash, MannKind
Apricus Biosciences' Promising Pipeline Points To A Bright Future
Seeking Alpha
Thursday, January 19, 2012 - 11:08am
tags:
Apricus Biosciences, erectile dysfunction, Vitaros, Pfizer, Abbott Laboratories
2 High-Flying Biotechs Face a New Hurdle
Motley Fool
Thursday, January 19, 2012 - 10:57am
tags:
Bayer, ONYX Pharmaceuticals, Aeterna Zentaris, regorafenib, Keryx
Forest Labs: This Company is Quickly Approaching the Patent Cliff
Motley Fool
Thursday, January 19, 2012 - 10:54am
tags:
Forest Labs, patents, patent cliff, Lexapro, Namenda
United Therapeutics: Look To This Biotech Stock For Healthy Growth
Seeking Alpha
Thursday, January 19, 2012 - 10:53am
tags:
United Therapeutics
Zalicus: Novartis Files 3 WIPO Patents; I Remain Bullish
Seeking Alpha
Thursday, January 19, 2012 - 10:48am
tags:
Novartis, Zalicus, WIPO, patents
Forbes Earnings Preview: Johnson & Johnson
Forbes
Thursday, January 19, 2012 - 10:39am
tags:
JNJ, earnings
Bristol, AstraZeneca Diabetes Drug Fails to Win FDA Backing
Bloomberg
Thursday, January 19, 2012 - 10:38am
tags:
AstraZeneca, FDA, Bristol-Myers Squibb, diabetes, Dapagliflozin
J&J Hid Risperdal Studies on Diabetes Risk From Regulators, Witness Says
Bloomberg
Thursday, January 19, 2012 - 10:37am
tags:
diabetes, JNJ, Risperdal
Roche’s Zelboraf for Melanoma Spurs Other Skin Cancer’s Growth, Study Says
Bloomberg
Wednesday, January 18, 2012 - 5:59pm
tags:
Roche, Zelboraf, melanoma, skin cancer

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.